Paper
0
373P Quality-of-life outcomes in patients with HER2-positive, locally advanced or metastatic breast cancer treated with eribulin mesylate in combination with trastuzumab and pertuzumab in the phase III JBCRG-M06/EMERALD study
Authors
Norikazu Masuda,S. Saji
Tsuguo Iwatani,Takako Takano,Koji Koizumi,Yoshiatsu Sagara,Yasuaki Naito,Michiko Tsuneizumi,Akinori Yoshimura,Mina Takahashi,J. Tsurutani,Masahiro Kitada,Hideo Tada,Toru Higuchi,Yutaka Kojima,Takayuki Kadoya,Hiroshi Hasegawa,Yasue Uchida,Sachi Morita
+17 authors
,Tomoki YamashitaJournal
Published
Sep 1, 2024
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This paper's license is marked as closed access or non-commercial and cannot be viewed on ResearchHub. Visit the paper's external site.